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Abstract 33 
 34 
Polybromodiphenyl ethers (PBDEs) were analyzed in blood serum of pregnant 35 
women and in cord blood serum of their newborns from a general population cohort (n 36 
= 174; Valencia, Spain). The most abundant PBDE congeners identified were BDE 47, 37 
BDE 99, BDE 153, BDE 154 and BDE 209. Their cord blood serum concentrations 38 
were about 45% of those in maternal serum but after lipid normalization median of total 39 
PBDEs was 9.6 ng/g lipid in cord serum (concentrations encompassing between not 40 
detected and 140 ng/g lipid) and 9.6 ng/ lipid in maternal serum(concentrations covering 41 
between not detected and 120 ng/g lipid). The distributions of these compounds were 42 
dominated by BDE 47 in both cases. In cord blood serum the decreasing order of 43 
abundance was BDE 47 > BDE 99 > BDE 209 > BDE 153 > BDE 154. The congener 44 
composition in maternal serum followed a similar trend: BDE 47 > BDE 153 > BDE 45 
154 > BDE 209 > BDE 99. The congener concentrations exhibited a higher degree of 46 
correlation in cord blood than in maternal serum. Use of the maternal determinants for 47 
categorization of the observed maternal and fetal PBDE concentrations only showed 48 
significant associations for the levels in umbilical cord. Neonates from rural areas 49 
exhibited statistically significantly lower concentrations than those from urban, semi-50 
urban or metropolitan sites. Maternal serum also showed this difference but the higher 51 
dispersion of the concentrations in maternal serum did not afford its recognition with 52 
statistical significance. The lower qualitative and quantitative variability in the PBDE 53 
concentrations of cord blood serum than maternal serum suggest that the latter is 54 
reflecting PBDE contributions from a wider diversity of sources than the former 55 
whereas cord blood sera seems to represent the long term standing stock of these 56 
compounds accumulated in the maternal tissues. 57 
 3
1. Introduction 58 
 59 
Polybromodiphenyl ethers (PBDEs) are a group of brominated flame retardants 60 
(BFRs) commonly used to reduce flammability of polymers and plastics. They have 61 
been added to many types of commercial and household products. PBDEs have similar 62 
properties to organochlorine compounds. They are persistent, highly lipophilic, 63 
accumulate in organisms and biomagnify through the food chain. Accordingly, they 64 
have become ubiquitous in the environment and in human population (Hites 2004). 65 
Three technical PBDE mixtures have been produced commercially. They are 66 
known by their average bromine composition. Penta-BDE, mainly pentabromodiphenyl 67 
congeners, was mainly used in flexible polyurethane foam for soft furnishing. Octa-68 
BDE, mainly octabromodiphenyl congeners, was used in acrylonitrile butadiene styrene 69 
resins. Deca-BDE, mainly decabromodiphenyl ether, is used in a variety of polymeric 70 
materials (Alaee et al., 2003). Due to health concerns and their widespread occurrence in 71 
environmental and human samples, the pentaBDE and octaBDE technical mixtures 72 
were banned by the European Union (EU) in 2004 and their production ceased in 73 
North America. Recently, the Stockholm Convention on Persistent Organic Pollutants 74 
(SCPOPs) decided to include the following mixtures in their list: tetraBDE (defined as 75 
BDE 47), pentaBDE (defined as BDE 99), hexaBDE (defined as BDE 153 and BDE 76 
154) and heptaBDE (defined as BDE 175 and BDE 183) (SCPOPS,2010). Production 77 
and use of decaBDE has continued although its use was restricted in Europe last year 78 
(EBFRIP, 2009). 79 
Human exposure to these compounds is of concern due to their widespread 80 
occurrence and potential toxicity. PBDEs have been described to interfere on natural 81 
hormone activity causing neurotoxicological and negative reproductive effects 82 
(Eriksson et al., 2006; Legler, 2008). These toxic effects are potentially more harmful 83 
during brain development in the prenatal period than in the adult life. Endocrine 84 
disruption can lead to serious deficits in neuropsychological functions in infants (Weiss, 85 
2000). Recent studies have shown neurodevelopment deficits related to background 86 
prenatal BDE levels (Herbstman et al., 2010; Roze et al., 2009). Moreover, other 87 
negative effects such as cryptorchidism in newborn boys (Main et al., 2007) and lower 88 
birth weight and length (Chao et al., 2008) have been associated to exposure to low 89 
PBDE doses. 90 
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The studies on PBDE concentrations in human tissues have been reviewed 91 
recently (Frederiksen et al., 2009a). Some of them concern both mothers and newborns 92 
(Antignac et al., 2009; Bi et al., 2006; Gomara et al., 2007; Kawashiro et al., 2008; 93 
Mazdai et al., 2003; Meironyte Guvenius et al., 2003). However, in some cases the 94 
number of subjects studied was small and many of them were focused on the lower 95 
brominated BDE congeners. Data of BDE 209 in prenatal exposure is scarce, probably 96 
due to analytical difficulties (Stapleton, 2006). In addition, these previous studies have 97 
shown dissimilar conclusions. In some cases, the same PBDE concentrations were 98 
found in mother and infant sera (Mazdai et al., 2003) and in others these concentrations 99 
were significantly different (Bi et al., 2006; Gomara et al., 2007; Meironyte Guvenius et 100 
al., 2003). Exposure to PBDEs is attributed to a combination of diet and indoor 101 
environment (Wilford et al., 2005). However, more information is needed on the 102 
influence of maternal determinants on PBDE accumulation. 103 
Accordingly, the present study is addressed to investigate the occurrence of 104 
PBDEs, including low and high brominated congeners, in maternal and umbilical cord 105 
serum. The transfer of these compounds between mother and fetus is evaluated. The 106 
influence of demographic determinants such as maternal age, previous lactation, pre-107 
pregnant body mass index (BMI), residence site, education level and others on PBDE 108 
concentrations have also been considered.  109 
 110 
2. Material and Methods 111 
 112 
2.1. Population and study design 113 
 114 
The study sample was drawn from a cohort established in Valencia as part of the 115 
INMA (Environment and Childhood) study, a Spanish multicenter mother-child cohort 116 
study that analyzes the influence of prenatal environmental exposures on growth, 117 
development and health from early fetal life until childhood. The study design is 118 
reported elsewhere (Ribas-Fito et al., 2006). The inclusion criteria for mothers in the 119 
cohort were: at least 16 years old, singleton pregnancy, no assisted conception, no 120 
chronic hypertension, delivery foreseen at the reference hospital and no communication 121 
handicap. In addition, mothers receiving TH supplements or anti-TH drugs were 122 
excluded. The study protocol was approved by the Ethics Committee of the reference 123 
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hospital and informed consent was obtained for every participant. 855 women were 124 
enrolled in the study during 2003-2005. Maternal blood samples (n=806) were collected 125 
during the first trimester of gestation (median= 12 weeks; range= 10-13 wks). Women 126 
who withdrew, were lost to follow-up, had induced or spontaneous abortions and fetal 127 
deaths were excluded. A total sample of 787 women was followed until delivery 128 
between May 2004 and February 2006. 527 cord blood samples were successfully 129 
collected. For logistical reasons and due to budget limitations, we present data on the 130 
first consecutive 174 maternal and cord serum samples. No differences in maternal BDE 131 
concentrations are expected during pregnancy (Meijer et al., 2008). 132 
 133 
2.2. PBDEs analysis 134 
 135 
The laboratory analytical methods and quality control procedures have been 136 
described elsewhere (Vizcaino et al., 2009). A total of 14 PBDE congeners were 137 
analyzed: BDE 17 and BDE 28 (tribromo), BDE 47, BDE 66 and BDE 71 (tetrabromo), 138 
BDE 85, BDE 99 and BDE100 (pentabromo), BDE 153, BDE 154 and BDE 138 139 
(hexabromo), BDE 183 and BDE 190 (heptabromo) and BDE 209 (decabromo). 140 
Briefly, 1 ml of serum was spiked with the surrogate standard of 141 
decachlorobiphenyl (PCB 209) and vortex stirred for 30 s at 2,000 rpm. n-Hexane (3 142 
ml) was added, followed by concentrated sulfuric acid (2 ml). After reaction, the 143 
mixture was stirred for 30 s and the supernatant n-hexane phase was separated by 144 
centrifugation. The remaining sulfuric acid solution was re-extracted two times with 2 145 
ml of n-hexane (each by 30 s stirring and centrifugation). The combined n-hexane 146 
extracts (7 ml) were additionally cleaned with sulfuric acid (2 ml, stirring 30 s). Then, 147 
the n-hexane phase was separated by centrifugation and reduced to a small volume 148 
under a gentle nitrogen stream. The extract was transferred to gas chromatography (GC) 149 
vials using four 25 μl rinses of isooctane. BDE 118 (20 μl) and [13C]-BDE 209 (10 μl) 150 
were added as internal standards before injection.  151 
PBDEs were analyzed using an Agilent 6890N GC coupled to a 5975 mass 152 
spectrometer (Agilent Technologies, Palo Alto, CA, USA) operating in negative 153 
chemical ionization mode (NICI). The instrument was equipped with a low bleed SGE-154 
BPX5 MS fused silica capillary column (15 m long, 0.25 mm internal diameter and 0.10 155 
μm film thickness). Sample batches encompassed 9, 15 or 19 samples, depending on 156 
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laboratory material availability. One procedural blank was included in each sample 157 
batch. PBDE levels in blanks were negligible with exception of BDE 47, BDE 99 and 158 
BDE 209. In this case, blank levels were extracted from the corresponding sample 159 
batch. On average, they accounted for 2.6%, 10% and 11% of BDE 47, BDE 99 and 160 
BDE 209 of median concentrations. BDE compounds in the samples were considered as 161 
“non detected” if the corresponding blank in the batch was equal or higher than 30% of 162 
the compound measurements. Method detection limits (MDLs) were calculated as three 163 
times the standard deviation of the procedural blank levels. Instrumental detection limits 164 
were used for the congeners not detected in the procedural blanks. They were calculated 165 
by injection of standard solutions as three times the value of the signal-to-noise ratio 166 
(S/N). Detection limits ranged between 0.0006 and 0.006 ng/mL depending on the 167 
PBDE congener. PBDEs identification was based on retention time and mass spectral 168 
information. Quantification was performed by reference to linear calibration lines and 169 
correction by the surrogate and injection standards (Vizcaino et al., 2009). Percent 170 
recoveries of PCB 209 ranged between 41% and 101% (mean ± standard deviation = 64 171 
± 9.5). Final validation was made by analysis of reference material obtained from the 172 
Arctic Monitoring and Assessment Program (AMAP). We participate regularly in the 173 
AMAP Ring Test Proficiency Program for POPs in human serum (Centre de 174 
Toxicologie Institut National de Santé Publique du Québec, Québec, Canada) and the 175 
laboratory results usually were within 20% of the consensus values, including BDE 209 176 
concentrations.  177 
 178 
2.3. Lipid determination 179 
 180 
Total cholesterol and triglycerides were determined using colorimetric 181 
enzymatic methods in the General Biochemistry Laboratory of Hospital La Fe. Total 182 
serum lipid concentrations were calculated as described by Phillips et al. (1989). 183 
 184 
2.4. Demographic variables 185 
 186 
Information on residence (urban, metropolitan, semiurban, rural), country of birth 187 
(Spain, other countries), education (up to primary school, high school, university), 188 
maternal age (<25, 25-29, 30-34, ≥35 years), pre-pregnancy BMI (underweight, normal, 189 
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overweight, obese) and previous lactation (<6, >6 months) were obtained from a 190 
questionnaire administered at 10-13 weeks of gestation. Maternal blood samples were 191 
collected at this time. 192 
 193 
2.5. Data analysis 194 
 195 
Descriptive statistics were calculated for concentrations of PBDE compounds in 196 
maternal and umbilical cord serum. PBDE levels were expressed in pg/mL or were 197 
lipid-adjusted (ng/g), dividing serum residue levels by total serum lipid concentrations 198 
for comparision with the literature but statistical calculations were performed on fresh 199 
weight PBDE concentrations (pg/mL). Values of half detection limits were introduced 200 
in the database when measurable quantities of the analytes were not detected. Only 201 
congeners found above quantification level in more than 30% of the samples analyzed 202 
were considered. PBDE concentrations were not normally distributed, they were right-203 
skewed even after log-transformation. They did not show normal distribution so 204 
eventually we did not use any transformation. Normal distribution was examined 205 
according to the Kolmogorov-Smirnov method. Spearman correlations were used to 206 
examine associations between maternal and cord serum levels. Kruskal-Wallis and 207 
Mann-Whitney U tests were used to evaluate associations between PBDE levels and 208 
sociodemographic variables. Statistical significance was fixed at p<0.05 (two sided). 209 
Statistical analysis was done with the Statistical Package for Social Sciences version 210 
15.0 (SPSS Inc., Chicago, IL, USA). 211 
 212 
3. Results and Discussion 213 
 214 
3.1. Characteristics of the population included in the study 215 
 216 
Six determinants of the mothers participating in the study are shown in Table 1. 217 
More than 90% of the total population was originally born in Spain. The proportion of 218 
those living in rural areas was small (2%). About 32% had a primary school degree, 219 
39.1% had secondary degree and 25.9% an university degree. The mean age at delivery 220 
was 30.1(4.8). 48% were multiparous and 20% had previously breastfed for more than 6 221 
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months. Standardized BMI categories showed that 24.1% of the mothers were 222 
overweight and 10.9% were obese.  223 
 224 
3.2. PBDEs concentrations in mothers and newborns 225 
 226 
BDE 17, BDE 66, BDE 71, BDE 85 BDE 138 and BDE 190 were not detected 227 
in any of the samples analyzed. BDE 28 (LOD = 0.0006 ng/mL), BDE 100 (LOD = 228 
0.0004 ng/mL) and BDE 183 (LOD = 0.0012 ng/mL) were found above limit of 229 
detection in less than 10% of the samples. These congeners were therefore not included 230 
in the following sections. Mean, median and concentration ranges of the most abundant 231 
PBDEs, BDE 47, BDE 99, BDE 153, BDE 154 and BDE 209, are shown in Table 2. 232 
Total PBDEs encompassed between not detected and 140 ng/g lipid in cord serum and 233 
between not detected and 120 ng/g lipid in maternal serum. BDE 47 was the dominant 234 
congener in both, cord and maternal serum accounting for 28% and 45% of total PBDEs 235 
respectively. Congener concentrations in the cord serum samples tended to decrease at 236 
higher number of bromine substituents except in the case of BDE 209 (Fig. 1) which 237 
was the third most abundant congener. 238 
BDE 47 was also the predominant congener in maternal serum but BDE 153 and 239 
BDE 154 were present in higher concentrations than BDE 99. Serum PBDE 240 
distributions with BDE 47 predominance and higher relative proportion of BDE 153 241 
than BDE 99 (but lower concentration of BDE 154 than BDE 99) have been found in 242 
Stockholm (Meironyte Guvenius et al., 2003), Kashiva (Japan; Kawashiro et al., 2008) 243 
and Guangzhou (Bi et al., 2006). In contrast, distributions with predominance of BDE 244 
99 over BDE 153 and BDE 154 have been found in Indiana (Mazdai et al., 2003), 245 
Salinas Valley (Bradman et al., 2007) and Madrid (Gomara et al., 2007). In some cases, 246 
BDE 153 has been found to dominate in the PBDE distribution (Groningen; Meijer et 247 
al., 2008). These differences in composition can be interpreted to reflect diverse 248 
contributions of the above described PBDE commercial mixtures. In addition, the 249 
dominance of BDE 47 may reflect contributions from environmentally transformed 250 
mixtures in which this congener becomes predominant (Keum and Li, 2005; Eriksson et 251 
al., 2004; Robrock et al., 2008). 252 
The concentrations found in the present cohort are similar to those reported in 253 
other Spanish cohorts, e.g. Madrid (mothers, n = 61, median 12 ng/g lipid; newborns, n 254 
= 44, median 17 ng/g lipid; Gomara et al., 2007), Menorca (newborns, n = 92; 6.2 ng/g 255 
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lipid; Carrizo et al., 2007), as well as in other European sites, e.g. Toulouse (n = 93; 8.8 256 
ng/g lipid in mothers and 12 ng/g lipid in newborns; Antignac et al., 2009), or in Asian 257 
locations such as Guiyu (n = 102; 14 ng/g lipid in newborns; Wu et al., 2010). They are 258 
higher than in Stockholm (n = 15; 1.9 ng/g lipid in mothers and 1.3 ng/g lipid in 259 
newborns; Meironyte Guvenius et al., 2003), Groningen (n = 90; 3.3 ng/g lipid in 260 
mothers and 1.9 ng/g lipid in newborns; Meijer et al., 2008), Guangzhou (n = 27; 3.9 261 
ng/g lipid; Bi et al., 2006), Chaonan (n = 51; 5.2 ng/g lipid in newborns; Wu et al., 262 
2010), Kashiwa (n = 16; 4.6 ng/g lipid; Kawashiro et al., 2008) and Japan (n = 89; 2.9 263 
ng/g lipid; Inoue et al., 2006). On the contrary, the concentrations from the Valencian 264 
cohort were much lower than concentrations reported in populations from north 265 
America, e.g. Indianapolis (n = 12; 37 ng/g lipid in mothers and 39 ng/g lipid in 266 
newborns; Mazdai et al., 2003), Salinas Valley (n = 24; 21 ng/g lipid in mothers; 267 
Bradman et al., 2007), Baltimore (n = 297; 27 ng/g lipid in newborns; Herbstman et al., 268 
2007) and Manhattan (n = 210; 19 ng/g lipid in newborns; Herbstman et al., 2010).  269 
In any case, there is a large variation of PBDE concentrations in the samples 270 
analyzed. A group of highly exposed mothers could be identified, 16 participants were 271 
in the highest decile of ΣPBDEs and their concentrations were five times higher than the 272 
average values of the other cohort participants (Table 3). This high variability has been 273 
observed in previous studies (Kawashiro et al., 2008). The group of the highest decile 274 
exhibits concentration values that are higher than those in the upper concentration range 275 
of previously described cases. This group of highly exposed individuals reflect specific 276 
PBDE sources since it exhibits a distribution also dominated by BDE 47 but higher 277 
concentrations of BDE 99 than BDE 153 and BDE 154. This distribution is different 278 
from the previously described average PBDE composition in the mothers (Table 2). 279 
 280 
3.3 PBDE composition in umbilical cord vs maternal serum 281 
 282 
All congener concentrations are lower in umbilical cord than in maternal serum 283 
when reported on fresh weight basis (pg/ml; Table 2). On average PBDEs in cord blood 284 
are about 45% of those in maternal serum. However, normalization of these 285 
concentrations on lipid basis provided quite similar levels in both matrices for all 286 
congeners (Table 2). It is important to highlight that the fresh weight concentrations of 287 
the congeners are not correlated with total lipid serum content (data not shown). 288 
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Accordingly, fresh weight concentrations were used for the calculations of correlations 289 
and other tests. 290 
In qualitative terms, similar distributions are found both in maternal and cord 291 
sera. Thus, even BDE 209, which is characterized by a high molecular size due to its ten 292 
bromine substituents (Sölder et al., 2009), is found in pre-natal children in average 293 
concentrations that are about half those found in maternal serum. However, these 294 
concentrations are even higher in cord blood serum when normalized to lipid content 295 
(Table 2). High concentrations of this compound have also been found in placenta 296 
(Frederikssen et al., 2009b). BDE 209 has also been found in cord serum in previous 297 
studies, e.g. Guiyu (median 4.2 ng/g lipid; Bi et al., 2006), Chaonan (2.5 ng/g lipid; Bi 298 
et al., 2006) and Toulouse (27 ng/g lipid; Antignac et al., 2009). Anyhow, taking into 299 
account the short life of BDE 209 in humans (Thuresson et al., 2006) it seems that 300 
mothers must be exposed to it continuously to keep the observed serum concentrations 301 
and transfer to the fetus. 302 
Significant correlation coefficients between the concentrations of the different 303 
congeners in both mothers and newborns can be established (Table 4). In newborns all 304 
congeners except BDE 209 are correlated with a high degree of significance (p < 0.01; 305 
Table 4) although in some cases the coefficients are not very high. BDE 209 is 306 
correlated with BDE 47 and BDE 99 but not with BDE 153 and BDE 154. In maternal 307 
serum, significant correlations (p < 0.01) are found again between all PBDE congeners 308 
except BDE 209. In this group of samples BDE 209 exhibit a more dissimilar trend than 309 
in newborns which likely reflect a larger diversity of sources contributing to the PBDE 310 
composition in the former than in the latter. 311 
We only found statistically significant correlations between BDEs concentration 312 
in maternal and cord serum for BDE 209 (r2 = 0.152, p<0.05). Some authors found 313 
strong correlations between paired cord and maternal concentrations (n = 12; Mazdai et 314 
al., 2003), others only found weak correlations and not for all congeners (n = 21, Bi et 315 
al., 2006; n = 16, Kawashiro et al., 2008) while others did not find any (n = 72-90, 316 
Antignac et al., 2009; n = 44, Gómara et al., 2007). According to these antecedents, 317 
significant correlations between paired mother-fetus BDE concentrations were only 318 
found when the number of cases was small. The lack of correlation at larger sample 319 
numbers could reflect different factors. Placenta could prevent the free pass of PBDEs 320 
into the fetal compartment leading to different accumulation patterns of these 321 
compounds (Frederikssen et al., 2009b). Differences between mother and fetus for 322 
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congener metabolization could also contribute to the lack of correlation since fetus do 323 
not have their detoxification mechanisms fully developed (Olsen, 2000). We think that 324 
this issue is still open. 325 
 326 
3.4 Maternal determinants of prenatal PBDE exposure  327 
 328 
Maternal socio-economic characteristics such as residence site, educational 329 
level, age, BMI and previous lactation were assessed in order to know their influence on 330 
PBDE concentrations. Significant associations were found for total PBDEs and 331 
residence site and BDE 153 and age in umbilical cord but not in maternal serum (Table 332 
5). The lack of statistically significant correlation with BMI, lactation or educational 333 
level has already been observed in other studies (Antignac et al., 2009; Gomara et al., 334 
2007; Mazdai et al., 2003; Meironyte Guvenius et al., 2003; Bradman et al., 2007). 335 
However, there is one previous study reporting one association between PBDE cord 336 
serum concentrations and BMI, previous lactation and education level (Herbstman et al., 337 
2007). 338 
Geographic differences have been found for PBDE concentrations in cord 339 
serum. Neonates from rural areas have lower concentrations than those born in urban, 340 
semi-urban or metropolitan sites (Table 5; Fig. 2). Although these data must be 341 
interpreted cautiously since the number of cases from rural areas was small (n = 4). 342 
These differences were also observed in breast milk and maternal serum from Japan 343 
(Inoue et al., 2005). In the cohort of Valencia the difference is observed in cord serum 344 
but not in maternal serum. PBDEs in maternal serum probably reflect contributions 345 
from a higher diversity of sources and therefore higher variability which hinders the 346 
observation of differences such as location. In contrast, cord serum likely records PBDE 347 
inputs from maternal sources that result from larger time period averages involving 348 
lower dispersion of concentrations and composition. This lower dispersion of PBDE 349 
concentrations in cord serum facilitates the observation of long term geographic 350 
pollution differences. Thus, PBDEs from newborns of mothers living in rural sites 351 
exhibit significant lower values than in urban, semi-urban or metropolitan sites whereas 352 
higher dispersion in the PBDE concentrations of the mothers does not afford a 353 
statistically significant identification of this difference (Fig. 2). 354 
 355 
 356 
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4. Conclusions 357 
 358 
The most abundant PBDE congeners in both newborns and their mothers are 359 
BDE 47, BDE 99, BDE 153, BDE 154 and BDE 209. The summed concentrations of 360 
these congeners in cord blood serum are about 45% of those observed in maternal 361 
serum. However, when these measurements are normalized by lipid content about the 362 
same concentrations are observed. 363 
In qualitative terms, the distributions of these major PBDEs are similar in both 364 
types of samples being dominated by BDE 47. In cord blood serum this distribution 365 
exhibits a progressive decay from this less brominated congener until BDE 154 366 
involving relative concentration decreases at higher degree of bromination. This trend is 367 
not followed by BDE 209 that was the third most abundant congener. The congener 368 
composition in maternal serum follows a similar trend but BDE 153 is found in higher 369 
concentration than BDE 99. The concentrations between congeners exhibit a higher 370 
degree of correlation in cord blood than in maternal serum. These differences may 371 
indicate that maternal serum is reflecting PBDE contributions from a wider diversity of 372 
sources than cord blood serum which seems to represent the long term standing stock of 373 
these compounds accumulated in the maternal tissues. 374 
Categorization of the observed PBDE concentrations by maternal determinants 375 
has only shown some significant associations for the levels in umbilical cord but not in 376 
maternal serum. Neonates from rural areas exhibit statistically significantly lower 377 
concentrations than those born in urban, semi-urban or metropolitan sites. Maternal 378 
serum also shows this difference but the higher dispersion of the concentrations in this 379 
type of samples does not afford its recognition with statistical significance. 380 
 381 
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FIGURE CAPTION 508 
Figure 1: Median concentrations (pg/mL) of the major BDE congeners found in 509 
maternal and umbilical cord serum. 510 
 511 
Figure 2: Relationship between PBDE levels in cord (a) and maternal (b) serum and 512 
residence site in the INMAValencia cohort 2004-2006. Points refer to geometric means 513 
and error bars represent 95% CI (n = 174; urban = 22, metropolitan = 82, semiurban = 514 
66; rural = 4). 515 
